Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-08-25Clinical Trial Update: Surgical Approach for Primary Hyperparathyroidism in the Elderly [NA]
The clinical trial NCT01484379 investigating surgical approaches for primary hyperparathyroidism in elderly patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-21Clinical Trial Update: Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism
A multicenter registry evaluating preoperative imaging for primary hyperparathyroidism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating the early effect of Vitamin D in primary hyperparathyroidism has been withdrawn. The study relates …
-
CLINICAL_TRIALS withdrawal · 2014-12-05Clinical Trial Update: One Week Comparison Study of PTH and PTHrP Infusions [Phase 1]
A Phase 1 trial evaluating infusions of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) for osteoporosis and relat…
-
CLINICAL_TRIALS withdrawal · 2014-09-22Clinical Trial Update: Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) [Phase 2]
A Phase 2 trial of Lunacalcipol (CTA018) for chronic kidney disease stage 5 with secondary hyperparathyroidism has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-05-21Clinical Trial Update: Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease [NA]
A clinical trial evaluating the effects of Vitamin D on renal blood flow, proteinuria, and inflammation in chronic kidney disease was withdr…
-
CLINICAL_TRIALS withdrawal · 2014-05-06Clinical Trial Update: Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism [NA]
A clinical trial evaluating a High Intensity Focused Ultrasound (HIFU) device to treat secondary hyperparathyroidism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-11-16Clinical Trial Update: The Effects of Alendronate After Cure of Primary Hyperparathyroidism [Phase 4]
A Phase 4 clinical trial evaluating the effects of alendronate after cure of primary hyperparathyroidism has been withdrawn.
-
EMA withdrawal · 2009-05-14EMA Withdrawn: Parareg (cinacalcet) — Dompé Biotec S.p.A.
EMA withdrawn status for Parareg (cinacalcet) by Dompé Biotec S.p.A., with therapeutic areas including hypercalcemia, parathyroid neoplasms,…